Topiramate Tablet
Product Images NDC 71335-0337
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-0337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)
Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)
The text describes the change in the monthly migraine period rate during the double-blind phase using Topamax medication. The medication was taken at a dosage of either 100 or 200 milligrams per day. The change in migraine period rate is indicated to be a significant decrease, as represented by the asterisks in the final line.*
Label (Lbl713350337)
This is a list of information related to a medication called Topiramate. The medication is made by Cipla and comes in 100mg tablets in orange and round shape with the imprint code "124". It should be stored at room temperature and kept away from children. The image includes details on the expiration date and NDC code.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.